RBM24

Across TCGA pan-cancer cohorts, RBM24 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated RBM24 data layer compared with 3 for mutation status.

The strongest signal is observed in uveal melanoma (UVM), where higher RBM24 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RBM24 expression acts as an unfavorable survival marker, although some lineages such as BRCA and KIRC show a favorable association.

UVM, MESO, and BRCA are the cancer types where RBM24 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Median	All	0.582	0.900	<.001	139	view →
MESO	OS	Median	All	0.395	0.689	<.001	100	view →
BRCA	OS	Tertile	All	0.953	0.887	<.001	87	view →
HNSC	OS	Median	All	0.598	0.724	<.001	76	view →
BLCA	OS	Tertile	All	0.554	0.716	.001	62	view →
LGG	OS	Median	All	0.726	0.891	<.001	51	view →
KIRC	DFS	Tertile	All	0.926	0.815	.013	41	view →
UCEC	DFS	Quartile	IV	0.924	0.311	.007	32	view →
ACC	DFS	Tertile	All	0.514	0.809	.004	28	view →
DLBC	DFS	Median	All	0.579	1.000	.007	28	view →
STAD	DFS	Tertile	II,III,IV	0.601	0.856	.007	27	view →
UCS	DFS	Quartile	II,III,IV	0.690	0.162	.002	26	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

RBM24–UVM (DFS)

Open the UVM breakdown →